<DOC>
	<DOCNO>NCT02066207</DOCNO>
	<brief_summary>The purpose study evaluate pharmacokinetic drug interaction atorvastatin fenofibrate healthy subject .</brief_summary>
	<brief_title>CKD-337 Drug Interaction Study</brief_title>
	<detailed_description />
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Fenofibrate</mesh_term>
	<criteria>A healthy male volunteer 19 55 year old . BMI 18.5 27 . Able participate entire trial Signed informed consent form prior study participation . Clinically significant digestive system , cardiovascular system , respiratory system , endocrine system , hepatic system , renal system sit SBP &lt; 100mmHg sit SBP ≥ 150mmHg sit DBP &lt; 70mmHg sit DBP ≥ 100mmHg Have acute infection history within 14 day Have allergic disease need treat Have hypersensitivity reaction history IP specific drug . AST , ALT Total bilirubin &gt; UNL * 1.5 Estimated GFR &lt; 60 ml/min Genetic problem galactose intolerance , Lapp lactase deficiency , glucosegalactose malabsorption A heavy smoker ( cigarette &gt; 10 cigarette per day ) A heavy alcohol consumer ( alcohol &gt; 140g/week ) A heavy grapefruit consumer ( 1cup per day ) Have history drug abuse show positive urine drug test . Administrated IP within 60 day prior screen Rhabdomyolysis include history family history genetic muscle disease Positive HIV antibody , HBsAg , HCV antibody test Previously donate whole blood within 60 day component blood within 30 day Subject take ethical drug herbal medicine within 30 day Clinically significant laboratory test result An impossible one participate clinical trial investigator 's decision include reason</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2014</verification_date>
</DOC>